ArticlePloS one2012

Impact of isoniazid resistance-conferring mutations on the clinical presentation of isoniazid monoresistant tuberculosis.

Raymund Dantes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.